The use of digital technology and biomarkers in healthcare is growing rapidly and represents an opportunity to improve the efficiency of clinical trials. Developing digital biomarkers may lead to more objective, unbiased assessments and patient-oriented endpoints in clinical trials with the potential for real-world applications.
Presented by Brian Johnson- Director, Applied Innovation & Process Improvement, Otsuka
